Stock Analysis · Figs Inc (FIGS)

Stock Analysis · Figs Inc (FIGS)

Overview

Figs, Inc. (FIGS) is an apparel company focused on healthcare professionals. Its best-known products are scrubs, along with related workwear and accessories designed for medical and other clinical settings. The company’s positioning is built around branded, fit- and function-focused products, with a strong emphasis on direct relationships with customers through its own digital channels.

Figs’ revenue is primarily generated through selling its products directly to consumers (for example, through its website and mobile app). Based on the company’s business description in its SEC filings, the main revenue streams are typically:

  • Scrubs (core apparel) — the largest contributor
  • Other apparel / outerwear — smaller than scrubs
  • Accessories (such as bags, socks, and related items) — generally the smallest category

The company’s filings should be consulted for the most current category breakdown, as percentages by product line are not always disclosed in a consistent way across periods.

Business snapshot from recent annual results: total revenue increased from about $419.6M (2021) to $555.6M (2024). Over the same period, profitability tightened materially: net income moved from about -$9.6M (2021) to about $2.7M (2024), with operating income also compressing by 2024.

Across 2021–2024, revenue rose steadily (about $419.6M to $555.6M), while operating income fell from roughly $10.1M (2021) to about $2.3M (2024). A key swing factor is that operating expenses grew over time (about $290.2M in 2021 to about $373.4M in 2024), which reduced operating profit despite higher gross profit.

Key Figures

MetricValueIndustry
DateFeb 08, 2026
Context
SectorConsumer Cyclical
IndustryApparel Manufacturing
Market Cap $1.77B
Beta 1.30
Fundamental
P/E Ratio 97.6422.80
Profit Margin 3.03%4.94%
Revenue Growth 8.20%1.60%
Debt to Equity 13.09%109.04%
PEG N/A
Free Cash Flow $21.99M

Figs’ market capitalization is about $1.77B. The stock’s beta (~1.30) suggests it has tended to move more than the broader market. Recent valuation and operating metrics show a mix of faster growth than the industry median but lower profitability: P/E ~97.6 vs an industry median ~22.8, profit margin ~3.0% vs industry median ~4.9%, and YoY revenue growth ~8.2% vs industry median ~1.6%. Leverage appears relatively conservative with debt-to-equity ~13% versus an industry median ~109%. Trailing twelve-month free cash flow is about $22.0M.

Growth (Medium)

Figs operates in a large, established end market—workwear for healthcare professionals—where demand is tied to employment levels in healthcare, replacement cycles for uniforms, and customer preferences. This is not typically a “hypergrowth” category, so longer-term expansion often depends on capturing share through brand strength, product innovation, and expanding into adjacent categories (for example, non-scrub apparel items or new customer segments within healthcare and related professions).

The company’s strategy—building a recognizable brand and selling predominantly through its own channels—can support growth by improving customer retention and enabling new product launches without relying entirely on wholesale partners. This approach can also help the company learn from customer behavior more quickly (for example, what fits, colors, or styles are popular), though it also means the company bears more responsibility for driving traffic and demand through marketing.

Year-over-year revenue growth decelerated significantly from the very high levels seen in 2021–2022 (for example, ~42.7% in late 2021 and ~20%–25% in parts of 2022) to low single digits around 2023–2024, then improved again into 2025 (reaching roughly 8.2% in the most recent point shown). This pattern is consistent with an early surge followed by normalization, with a more recent re-acceleration that would need to persist to materially change the longer-run growth profile.

Free cash flow has been volatile over the last several years: positive in 2021–2022, negative around early 2023 (about -$35.9M at one point), then strongly positive in 2024 (peaking around $99.3M) before moderating to about $60.9M in early 2025 and roughly $22.0M most recently. For a consumer brand, sustained free cash flow matters because it can fund inventory needs, marketing, and product development without requiring significant external financing.

Potential catalysts for future growth (in a descriptive, non-predictive sense) typically include: successful new product category expansion, improved repeat purchasing, and more efficient customer acquisition spending. As with many consumer brands, the main question is whether the brand can drive durable demand while maintaining healthy margins.

Risks (High)

This article is for informational purposes only and does not constitute financial advice. Some content is AI-generated. See Disclaimer